Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP608509.RAnCvQvU9wQqtLpYgFDLzgHRrdfEPvgsWV7CNEjaJFtkM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP608509.RAnCvQvU9wQqtLpYgFDLzgHRrdfEPvgsWV7CNEjaJFtkM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP608509.RAnCvQvU9wQqtLpYgFDLzgHRrdfEPvgsWV7CNEjaJFtkM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP608509.RAnCvQvU9wQqtLpYgFDLzgHRrdfEPvgsWV7CNEjaJFtkM130_provenance.
- NP608509.RAnCvQvU9wQqtLpYgFDLzgHRrdfEPvgsWV7CNEjaJFtkM130_assertion description "[Because RALBP1 transports anthracycline and Vinca alkaloid drugs, as well as GS-E, and because it confers resistance to these drugs, we proposed that depletion or inhibition of RALBP1 should cause regression of human solid tumors that overexpress RALBP1 and augment chemotherapy efficacy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP608509.RAnCvQvU9wQqtLpYgFDLzgHRrdfEPvgsWV7CNEjaJFtkM130_provenance.
- NP608509.RAnCvQvU9wQqtLpYgFDLzgHRrdfEPvgsWV7CNEjaJFtkM130_assertion evidence source_evidence_literature NP608509.RAnCvQvU9wQqtLpYgFDLzgHRrdfEPvgsWV7CNEjaJFtkM130_provenance.
- NP608509.RAnCvQvU9wQqtLpYgFDLzgHRrdfEPvgsWV7CNEjaJFtkM130_assertion SIO_000772 17483352 NP608509.RAnCvQvU9wQqtLpYgFDLzgHRrdfEPvgsWV7CNEjaJFtkM130_provenance.
- NP608509.RAnCvQvU9wQqtLpYgFDLzgHRrdfEPvgsWV7CNEjaJFtkM130_assertion wasDerivedFrom befree-2016 NP608509.RAnCvQvU9wQqtLpYgFDLzgHRrdfEPvgsWV7CNEjaJFtkM130_provenance.
- NP608509.RAnCvQvU9wQqtLpYgFDLzgHRrdfEPvgsWV7CNEjaJFtkM130_assertion wasGeneratedBy ECO_0000203 NP608509.RAnCvQvU9wQqtLpYgFDLzgHRrdfEPvgsWV7CNEjaJFtkM130_provenance.
- befree-2016 importedOn "2016-02-19" NP608509.RAnCvQvU9wQqtLpYgFDLzgHRrdfEPvgsWV7CNEjaJFtkM130_provenance.